Different binding of NF-Y transcriptional factor to DQA1 promoter variants

Human Immunology

Volumn 59, Issue 12, 1998, Pages 758-767

  Indovina, Paola ^a   Megiorni, Francesca ^a   Ferrante, Paola ^a   Apollonio, Ilaria ^a   Petronzelli, Fiorella ^a   Mazzilli, Maria Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BETA 2 MICROGLOBULIN; BETA ACTIN; DNA; GUANINE; HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHORETIC MOBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BLOTTING, NORTHERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0032403578     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00082-2     Document Type: Article

References (41)

1. Benoist C., Mathis D. Regulation of major histocompatibility complex class II genes X, Y and other letters of the alphabet . Annu Rev Immunol. 8:1990;681.
2. Glimcher L.H., Kara C.J. Sequences and factors a guide to MHC class II transcription . Annu Rev Immunol. 10:1992;13.
3. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P.L. Natural history of HLA expression during tumour development. Immunol Today. 14:1993;491.
4. Reith W., Steimle V., Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today. 16:1995;539.
5. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes lessons from a disease . Annu Rev Immunol. 14:1996;301.
6. Louis-Plence P., Moreno C.S., Boss J.M. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J Immunol. 159:1997;3899.
7. Fontes J.D., Jabrane-Ferrat N., Peterlin B.M. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J Mol Biol. 270:1997;336.
8. Mantovani R., Pessara U., Tronche F., Li X.Y., Knapp A.M., Pasquali J.L., Benoist C., Mathis D. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO. 11:1992;3315.
9. Wright K.L., Vilen B.J., Itoh-Lindstrom Y., Moore T.L., Li G., Criscitiello M., Cogswell P., Badley Clarke J., Ting J.P.Y. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding factors. EMBO. 13:1994;4042.
10. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA. 91:1994;554.
11. Bellorini M., Lee D.K., Dantonel J.C., Zemzoumi K., Roeder R.G., Tora L., Mantovani R. CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acid Res. 25:1997;2174.
12. Didier D.K., Schiffenbauer J., Woulfe S.L., Zacheis M., Schwartz B.D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA. 85:1988;7322.
13. Ting J.P.Y., Painter A., Zeleznik-Le N.J., MacDonald G., Moore T.M., Brown A., Schwartz B.D. YB-1 DNA binding protein represses interferon gamma activation of class II major histocompatibility complex genes. J Exp Med. 179:1994;1605.
14. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficienti (or bare lymphocyte syndrome). Cell. 75:1993;135.
15. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533.
16. Collins T., Korman A.J., Wake C.T., Boss J.M., Kappes D.J., Fiers W., Ault K.A., Gimbrone M.A., Strominger J.L., Pober J.S. Immune interferon activates multiple class II major histocompatibility genes and the associated invariant chain in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA. 81:1984;4917.
17. De Préval C., Hadam M.R., Mach B. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N Engl J Med. 318:1988;1295.
18. Guardiola J., Maffei A., Lauster R., Mitchinson N.A., Accolla R.S., Sartoris S. Functional significance of polymorphism among MHC class II gene promoters. Tissue Antigens. 48:1996;615.
19. Reith W., Barras E., Satola S., Kobr M., Reinhart D., Sanchez C.H., Mach B. Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci USA. 86:1989;4200.
20. Kobr M., Reith W., Herrero-Sanchez C., Mach B. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol. 10:1990;965.
21. Kimura A., Sasazuki T. HLA-DQA gene is differently regulated from other HLA class II genes. Yooshida T.O., Wilson J.M. Molecular approaches to the study and treatment of human disease. 1992;Elsevier Press, Amsterdam.
22. Kimura A, Sasazuki T: Polymorphism in the 5' flanking region of the HLA-DQA1 gene and its relation to the DR-DQ haplotype. In Tsuji K, Aizawa M (eds): HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford University Press, 1992.
23. Morzycka-Wroblewska E., Harwood J.I., Smith J.R., Kagnoff M. Structure and evolution of the promoter regions of the DQA genes. Immunogenetics. 37:1993;364.
24. Brunnler G., Haas J.P., Fan L.A., Petzl-Erler M.L., Volgger A., Yao Z., Wassmuth R., Albert E.D., Middleton D., Barboni F., Contu L., Alvarez L.R., Ferrara G.B., Adorno D., Gorodezky C., Alaez C., Cerna M., Mazzilli M.C. DQA1 promoter polymorphism: 12th International Histocompatibility Workshop study. Charron D. Genetic diversity of HLA, functional and medical implication, Vol. 1. 1997;EDK publisher, Paris.
25. Haas J.P., Kimura A., Andreas A., Hochberger M., Keller E., Brunnler G., de la Paz Bettinotti M., Nevinny-Stickel C., Hildebrandt B., Sierp G., Sasazuki T., Albert E. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. Hum Immunol. 39:1994;31.
26. Reichstetter S., Krellner P.H., Meenzen C.M., Kalden J.R., Wassmuth R. Comparative analysis of sequence variability in the upstream regulatory region of the HLA-DQB1 gene. Immunogenetics. 39:1994;207.
27. Petronzelli F., Kimura A., Ferrante P., Mazzilli M.C. Polymorphism in the upstream regulatory region of DQA1 gene in the Italian population. Tissue Antigens. 45:1995;258.
28. Louis P., Vincent R., Cavadore P., Clot J., Eliaou J.F. Differential transcriptional activities of HLA-DR genes in the various haplotypes. J Immunol. 153:1994;5059.
29. Beaty J.S., West K.A., Nepom G.T. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1. Mol Cell Biol. 15:1995;4771.
30. Morzycka-Wroblewska E., Munshi A., Ostermayer M., Harwood J.I., Kagnoff M. Differential expression of HLA-DQA1 alleles associated with promoter polymorphism. Immunogenetics. 45:1997;163.
31. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription inititation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475.
32. Dorn A., Bollekens J., Staub A., Benoist C., Mathis D. A multiplicity of CCAAT box- binding proteins. Cell. 50:1987;863.
33. Chomcwynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
34. Diviacco S., Norio P., Zentilin L., Menzo S., Clementi M., Biamonti G., Riva S., Norio P., Zentilin L., Giacca M. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene. 122:1992;3013.
35. Ferrante P., Apollonio I., Del Nero A., Petronzelli F., Mazzilli M.C. Regulation of HLA gene expression. Minerva Biotec. 8:1996;32.
36. Haas J.P., Kimura A., Truckenbrodt H., Suschke J., Sasazuki T., Volgger A., Albert E.D. Early-onset pauciarticular juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter. Tissue Antigens. 45:1995;317.
37. Yao Z., Kimura A., Hartun K., Haas P.J., Volgger A., Brunnler G., Bonisch J., Albert E.D. Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. Immunogenetics. 38:1993;421.
38. She J.X. Susceptibility to type 1 diabetes HLA-DQ and DR revisited . Immunol Today. 17:1996;323.
39. Sollid M.L., Markussen G., Ek J., Gjerde H., Vardtal F., Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ a/b heterodimer. J Exp Med. 169:1989;345.
40. Matis L.A., Glimcher L.H., Paul W.E., Schwartz R.H. Magnitude of response of histocompatibility-restricted T cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci USA. 80:1983;6019.
41. Janeway C.A., Bottomly K., Babich J., Conrad P., Conzen S., Jones B., Kaye J., Katz M., McVay L., Murphy D.B., Tite J. Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today. 5:1984;99.